Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Para-n-benzene - sulfoxy-n containing doai – and said benzene...
Reexamination Certificate
2011-05-03
2011-05-03
Hui, San-ming (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Para-n-benzene - sulfoxy-n containing doai, and said benzene...
C546S340000
Reexamination Certificate
active
07935688
ABSTRACT:
The present invention provides a compound represented by the following general formula (I):or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing such a compound, and the like. The compound or a pharmaceutically acceptable salt thereof, the pharmaceutical composition containing such a compound, or the like is useful as a medicine or the like for therapy of benign prostatic hyperplasia, cancer, osteoporosis, psoriasis, secondary hyperparathyroidism, chronic glomerulonephritis, lupus nephritis and/or diabetic nephropathy and the like.
REFERENCES:
patent: 4713438 (1987-12-01), Harris et al.
patent: 5141948 (1992-08-01), Miyamoto et al.
patent: 5578625 (1996-11-01), Suzuki et al.
patent: 6166010 (2000-12-01), Itoh et al.
patent: 6518306 (2003-02-01), Christensen, IV
patent: 2006/0025474 (2006-02-01), Wallace et al.
patent: 3-232867 (1991-10-01), None
patent: 4-57812 (1992-02-01), None
patent: 7-97374 (1995-04-01), None
patent: 10-161332 (1998-06-01), None
patent: 2003-522129 (2003-07-01), None
patent: 2003-282270 (2003-10-01), None
patent: 2004-224766 (2004-08-01), None
patent: 93/25079 (1993-12-01), None
patent: 00/10958 (2000-03-01), None
patent: 01/10385 (2001-02-01), None
patent: 03/101978 (2003-12-01), None
patent: 2004/039864 (2004-05-01), None
patent: 2004/048309 (2004-06-01), None
patent: 2004/063345 (2004-07-01), None
patent: 2005/037755 (2005-04-01), None
patent: 2005/051893 (2005-06-01), None
patent: 2005/051898 (2005-06-01), None
patent: 2005/087700 (2005-09-01), None
patent: 2006/044602 (2006-04-01), None
Kaji, et al. Synthesis of a bifunctional epoxy monomer containing biphenyl moiety and properties of its cured polymer with phenol novolac., Journal of Applied Polymer Science, vol. 74, No. 3, pp. 690-698, 1999.
Iijima, et al. Synthesis and curing of new epoxy resins containing rigid structure in the backbone, Netsu Kokasei Jushi, vol. 14 No. 4, pp. 202-212, 1993.
Fissekis, et al. Synthesis of 5-carboxymethyluridine. Nucleoside from transfer ribonucleic acid, Biochemistry, vol. 9, pp. 3136-3142, 1970.
Pan, et al. New and efficient method for esterification of carboxylic acids with simple primary and secondary alcohols using cerium(IV)ammonium nitrate (CAN), Tetrahedron Letters, vol. 44, pp. 331-334, 2003.
Brown, et al. Serum Bone Gla-Protein: A Specific Marker For Bone Formation In Postmenopausal Osteoporosis, The Lancet, vol. 323, No. 8386, pp. 1091-1093, 1984.
Lian, et al. Contributions of nuclear architecture and chromatin to vitamin D-dependent transcriptional control of the rat osteocalcin gene, Steroids, vol. 66, No. 3-5, pp. 159-170, 2001.
Paredes, The Runx2 transcription factor plays a key role in the 1?,25-dihydroxy Vitamin D3-dependent upregulation of the rat osteocalcin (OC) gene expression in osteoblastic cells, The Journal of Steroid Biochemistry and Molecular Biology, vol. 89-90, pp. 269-271, 2004.
Peng, et al. Molecular Cloning and Characterization of a Channel-like Transporter Mediating Intestinal Calcium Absorption, The Journal of Biological Chemistry, vol. 274, No. 32, pp. 22739-22746, 1999.
Kurihara, et al. Design and synthesis of new ligand for VDR. The Pharmaceutical society of Japan, 114th I conference in Tokyo, 1994, 29 P2 I-405.
Boehm, et al. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3, Chemistry & Biology, vol. 6, No. 5, pp. 265-275, 1999.
Hosoda, et al. Ligands with dual vitamin D3-agonistic andandrogen-antagonistic activities, Bioorganic & Medicinal Chemistry Letters, vol. 15, pp. 4327-4331, 2005.
Yee, et al. Vitamin D Receptor Modulators for Inflammation and Cancer. Mini Reviews in Medicinal Chemistry, vol. 5, No. 8, 761-778, 2005.
Ma, et al. Identification and characterizationof noncalcemic, tissue-selective,nonsecosteroidal vitamin D receptor modulators, The Journal of Clinical Investigation, vol. 116, No. 4, pp. 892-904, 2006.
Takahashi, et al. Vitamin D receptor agonists: opportunities and challenges in drug discovery, Current Topics in Medicinal Chemistry, vol. 6, No. 12, pp. 1303-1316, 2006.
Haneishi Tsuyoshi
Kashiwagi Hirotaka
Ono Yoshiyuki
Shimizu Kazuki
Takahashi Tadakatsu
Chugai Seiyaku Kabushiki Kaisha
Cruz Kathrien
Hui San-ming
McDermott Will & Emery LLP
LandOfFree
Vitamin D-like compound does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vitamin D-like compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vitamin D-like compound will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2665219